4/16
09:20 am
maia
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
Low
Report
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
4/8
09:00 am
maia
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
Medium
Report
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
3/31
09:30 am
maia
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]
Low
Report
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]
3/31
09:30 am
maia
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer [TheStreet.com]
Medium
Report
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer [TheStreet.com]
3/31
09:15 am
maia
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Low
Report
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
3/27
08:38 am
maia
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
Medium
Report
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
3/5
04:31 pm
maia
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
Low
Report
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
3/4
04:00 pm
maia
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
Low
Report
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
3/2
11:11 pm
maia
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]
3/2
10:45 pm
maia
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Medium
Report
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
3/2
05:00 pm
maia
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
High
Report
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
2/24
09:18 am
maia
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market [Yahoo! Finance]
High
Report
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market [Yahoo! Finance]
2/24
08:45 am
maia
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
Medium
Report
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market